Wei Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wei Lu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Adrian R Guzman
Institute of Biosciences and Technology, Texas A&M University System Health Science Center, Houston, TX, USA
1 shared publication - Claudia J Chapa
Dell Pediatric Research Institute, UT Austin, Austin, TX, USA
1 shared publication - Edward J. Lammer
Children's Hospital Oakland Research Institute, Oakland, California
1 shared publication - Gary M. Shaw
Department of Pediatrics Stanford University Stanford California USA
1 shared publication - Huiping Zhu
Dell Pediatric Research Institute, Department of Nutritional Sciences, University of Texas at Austin, Austin, TX, USA
1 shared publication - M. Michele Pisano
Department of Molecular, Cellular and Craniofacial Biology, ULSD, University of Louisville, Louisville, KY 40202, USA
1 shared publication
Latest Publications
- Open Access
- 8 October 2010
- Published by Springer Nature in BMC Medical Genetics
- Vol. 11 (1) , 141
Genes encoding critical transcriptional activators for murine neural tube development and human spina bifida: a case-control study
Background: Spina bifida is a malformation of the neural tube and is the most common of neural tube defects (NTDs). The etiology of spina bifida is largely unknown, although it is thought to be multi-factorial, involving multiple interacting genes and environmental factors. Mutations in transcriptional co-activator genes-Cited2,p300,Cbp,Tfap2α,Carm1andCart1result in NTDs in murine models, thus prompt us to investigate whether homologues of these genes are associated with NTDs in humans.Methods: Data and biological samples from 297 spina bifida cases and 300 controls were derived from a population-based case-control study conducted in California. 37 SNPs withinCITED2,EP300,CREBBP,TFAP2A,CARM1andALX1were genotyped using an ABI SNPlex assay. Odds ratios and 95% confidence intervals were calculated for alleles, genotypes and haplotypes to evaluate the risk for spina bifida.Results: Several SNPs showed increased or decreased risk, includingCITED2rs1131431 (OR = 5.32, 1.04~27.30),EP300rs4820428 (OR = 1.30, 1.01~1.67),EP300rs4820429 (OR = 0.50, 0.26~0.50, in whites, OR = 0.7, 0.49~0.99 in all subjects),EP300rs17002284 (OR = 0.43, 0.22~0.84),TFAP2Ars3798691 (OR = 1.78, 1.13~2.87 in Hispanics),CREBBPrs129986 (OR = 0.27, 0.11~0.69),CARM1rs17616105 (OR = 0.41, 0.22~0.72 in whites). In addition, one haplotype block inEP300and one inTFAP2Aappeared to be associated with increased risk.Conclusions: Modest associations were observed inCITED2,EP300,CREBBP,TFAP2AandCARM1but notALX1. However, these modest associations were not statistically significant after correction for multiple comparisons. Searching for potential functional variants and rare causal mutations is warranted in these genes.
- 8 October 2010
- Published by Springer Nature in BMC Medical Genetics
- Vol. 11 (1) , 141
Open AccessGenes encoding critical transcriptional activators for murine neural tube development and human spina bifida: a case-control study
Background: Spina bifida is a malformation of the neural tube and is the most common of neural tube defects (NTDs). The etiology of spina bifida is largely unknown, although it is thought to be multi-factorial, involving multiple interacting genes and environmental factors. Mutations in transcriptional co-activator genes-Cited2,p300,Cbp,Tfap2α,Carm1andCart1result in NTDs in murine models, thus prompt us to investigate whether homologues of these genes are associated with NTDs in humans.Methods: Data and biological samples from 297 spina bifida cases and 300 controls were derived from a population-based case-control study conducted in California. 37 SNPs withinCITED2,EP300,CREBBP,TFAP2A,CARM1andALX1were genotyped using an ABI SNPlex assay. Odds ratios and 95% confidence intervals were calculated for alleles, genotypes and haplotypes to evaluate the risk for spina bifida.Results: Several SNPs showed increased or decreased risk, includingCITED2rs1131431 (OR = 5.32, 1.04~27.30),EP300rs4820428 (OR = 1.30, 1.01~1.67),EP300rs4820429 (OR = 0.50, 0.26~0.50, in whites, OR = 0.7, 0.49~0.99 in all subjects),EP300rs17002284 (OR = 0.43, 0.22~0.84),TFAP2Ars3798691 (OR = 1.78, 1.13~2.87 in Hispanics),CREBBPrs129986 (OR = 0.27, 0.11~0.69),CARM1rs17616105 (OR = 0.41, 0.22~0.72 in whites). In addition, one haplotype block inEP300and one inTFAP2Aappeared to be associated with increased risk.Conclusions: Modest associations were observed inCITED2,EP300,CREBBP,TFAP2AandCARM1but notALX1. However, these modest associations were not statistically significant after correction for multiple comparisons. Searching for potential functional variants and rare causal mutations is warranted in these genes.